Core Insights - Velocity Clinical Research has appointed Andrew (Drew) Reina as Chief Revenue Officer, effective immediately, to enhance its strategic partnerships and revenue growth [1][2][3] Company Overview - Velocity is a leading integrated site organization for clinical trials, operating over 70 sites with more than 200 investigators, partnering with pharmaceutical and biotechnology companies [7] - The company aims to set the standard for strategic relationships between multisite clinical research corporations, Sponsors, and CRO partners [2] Leadership and Experience - Drew Reina brings over two decades of global clinical research experience, previously serving as Vice President and Head of Sales at Fortrea, where he led a high-performing commercial organization [4][5] - His experience includes overseeing a $1 billion+ global portfolio at PPD's Biopharma segment, focusing on strategic partnerships and alliance management [5] Strategic Goals - As CRO, Drew will drive growth through strategic partnerships with Sponsors and CROs, aligning business development, marketing, and network operations to ensure consistent revenue performance [6] - The organization is positioned to meet the evolving needs of clinical research, helping to accelerate speed to market and alleviate burdens on sites and patients [4][6] Technological Advancements - Velocity operates a technology hub in India, developing innovative systems to leverage expansive site, patient, and historical performance data, enhancing efficiency in clinical trials [8]

[Music] [Applause] [Music] 17 years. That's how long it takes for clinically important research findings to make their way into widespread healthc care practice. 17 years.And for many findings, it doesn't happen at all. You could say that research is lost in translation. Ideas, discoveries with the potential of transforming lives remain buried in books and journals, never reaching the hands of the people who need them the most.This 17-year gap between practice and research, it's not just a statistic to me, ...

[Music] Bringing a life-saving drug to market requires analyzing massive amounts of complex data. The pharmaceutical industry needs a faster, more automated way to extract meaning and act on it. Ivia is using Agentic AI to do exactly that.Training AI agents to navigate more than a million data streams for clinical, medical, and commercial professionals. Its healthcare grade AI platform combines a growing set of AI agents, each designed to streamline how insights turn into action. Built with NVIDIA Neotron m ...